advanced search

Novaliq

Novaliq is a German ophthaltmic pharmaceutical company. The company’s products are centred on its proprietary water-free technology, EyeSol® for topical ocular drug delivery. Novaliq is focused on developing the technology for use in treatments for dry eye disease.


Visit Website

Headquarters
Novaliq GmbH
Im Neuenheimer Feld 515
D-69120 Heidelberg
Germany

Phone / Contact

T: +49 6221 50259-0
F: +49 6221 5 02 59 21
E: [email protected]

Connect

Novaliq is the developer of the first water-free technology for ocular drug delivery. It is a specialist pharmaceutical formulation technology company that develops in-house topical ophthalmic formulations for dry eye disease based on its proprietary technology.

Novaliq’s product portfolio includes:

  • CyclASol®, a preservative-free cyclosporine A solution for the treatment of moderate to severe dry eye disease.  CyclASol® is evaluated in the Phase IIb/III ESSENCE study.
  • NOV03, the first drug to treat evaporative dry eye disease associated with meibomian gland dysfunction. NOV03 is evaluated in the Phase II SEECASE study.
  • NovaTears®, a preservative-free eye lubricant for tear film stabilisation in evaporative dry eye disease. NovaTears® is marketed under CE-approval in Australia and New Zealand by AFT Pharmaceuticals and as EvoTears® in Europe by Ursapharm.

Novaliq is based in Heidelberg, Germany, with a scientific office in Cambridge, MA, US. The long-term shareholder is dievini Hopp BioTech holding GmbH, a private equity and venture capital firm active in the health and life science sectors.

Articles by Novaliq

OCULAR
Dr Christian Roesky
BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE
Christian Roesky discusses the underserved condition of dry eye disease, and presents two products in Novaliq’s pipelinefor the treatment of different types of DED.
OCULAR
Dr Christian Roesky
AQUEOUS-FREE OPHTHALMIC DELIVERY TECHNOLOGY
Traditional aqueous vehicles for topical ophthalmic medications suffer from a number of limitations. Christian Roesky reviews the benefits of EyeSol®, a proprietary aqueous-free drug delivery technology.
OCULAR
Dr Dieter Scherer
AN INTEGRATED PIPELINE OF OPHTHALMIC PRODUCTS BASED ON EYESOL™ DELIVERY TECHNOLOGY
Dieter Scherer describes two of Novaliq’s most advanced products: NovaTears®, a wetting agent for the ocular surface, and CyclASol®, a clear formulation of Cyclosporin A. Both products use Novaliq’s semifluorinated alkane technology, EyeSol®.
Top